June 27, 2024
admin
Medicamen Organics IPO GMP Guidance & Subscription Status at Chanakyanipothi.com,
👉A legacy of 31 Years.
India`s Oldest Investment & IPO website.
👉Most Trusted by Investors across India.
Table of Contents
Medicamen Organics IPO Post Listing Review:
The scrip is listed at Rs. 137, premium of 305.44% over the lssue price of Rs. 34. The listing has been quite above the expectations of the grey market players.
What was the last GMP of Medicamen Organics IPO?*
GMP Rs. 70
Subscription status of Medicamen Organics IPO
Medicaman Subscription ClosedPrice Rs. 34 Lot 4000 shares |
||||
| QIB x | NII x | RII x | Total x | Applications |
| 173.03 | 1340.73 | 1271.72 | 973.83 | 3,26,832 / 1271.72 x |
What is the business of Medicamen Organics?
Medicamen Organics is engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer. It markets its product to private pharma companies in domestic as well as international markets through third party distributors
or on loan license basis. Further, the Company is also strategically focusing on establishing a direct presence in international market for an instance in fiscal 2023, it has directly exported its product in Burundi. It has a track record of operating B2B model which covers contract manufacturing model. Its products are marketed across India as well as African, CIS and south East Asian Countries like Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya by its third-party distributor.
It has 2 WHO GMP approved manufacturing facilities located at 60 and 61, Sector 6A, I.I.E. SIDCUL, Ranipur, Haridwar 249403, Uttarakhand spread across 21,536 Sq. Ft. Its manufacturing facilities are capable of producing pharmaceutical formulations and products and has fully equipped quality control department with experienced and qualified staff to facilitate smooth manufacturing process. It has in-house testing laboratory and necessary infrastructure to test its raw materials and
finished products to match the quality standards. It is ISO 9001:2015 certified company. Its core strength lies in product development and documentation, which gives it an inherent strength in the market as we are regularly engaged in research and development and launching new products. This gives it an ever-evolving product list as well as better pricing in the market.
Its product portfolio consists of 84 products and comprises of wide range of drugs like, Anti-Bacterial, Anti Diarrheal, Anti Fungal, Anti-Malarial, Anti Diabetic, Proton Pump Inhibitor, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral and Non-steroidal anti-inflammatory drug (NSAIDS).
The Company is consistent in supplying of quality products round the year. Its products comply with requisite safety standards.
It is a quality conscious company. It is constantly striving to expand its line of products and it is always looking for complementary products that will add to its range of products.
Get more information about the company @ http://www.medicamenorganics.cohttp://www.medicamenorganics.com/
| Medicamen Organics IPO Details | |
| IPO opens on | 21 June 2024 |
| IPO closes on | 25 June 2024 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 3100000 Shares / Rs 10.54 Crore |
| * Fresh Issue | 3100000 Shares / Rs 10.54 Crore |
| * Offer for Sale | – Shares / Rs – Crore |
| Market Maker Portion | 172000 Shares |
| Net offer to Public | 2928000 Shares/ Rs.9.95 Crore |
| Face Value per share | Rs. 10 |
| Price Band | Rs.32-34 |
| Employee discount | Rs. 0 per share |
| Retail Lot Size | 4000 Shares |
| Listing will at | NSE SME |
| Shares offered in Medicamen Organics IPO | ||
| Shares | Rs. (Crore) | |
| QIB (0%) | 1464000 | 4.98 |
| NII (50%) | 439200 | 1.49 |
| RII (50%) | 1042800 | 3.48 |
| Total Shares | 2928000 | 9.95 |
| Retail portion will be oversubscribed by | 261 | |
| Forms | ||
| How much Shares to Apply in Medicamen Organics IPO? | ||
| Min Retail Application | 4000 Shares | Rs. 136000 |
| Min HNI Application | 8000 Shares | Rs.272000 |
Who are the Promoters of Medicamen Organics IPO?
Mr. Ranjit Kulladhaja Mayengbam and Mrs. Gangarani Devi Mayengbam are the company’s promoters
What are the Objects of Medicamen Organics IPO?
The Offer comprises of a Fresh Issue of Equity shares & also offer for sale.
The company intends to utilize the proceeds of the Offer to meet the following objects: –
1. Funding Working Capital Requirements of the Company
2. Repayment/ Prepayment of Certain Borrowings availed by the Company
3. General corporate purposes
| Medicamen Organics IPO Tentative timetable | |
| IPO opens on | 21 June 2024 |
| IPO Closes on | 25 June 2024 |
| IPO Allotment on | 26 June 2024 |
| Refund Initiation | 27 June 2024 |
| Credit of Shares | 27 June 2024 |
| Listing on | 28 June 2024 |
| Registered Office of the Company Medicamen Organics Limited 10 Community Centre, No 2 Ashok Vihar Phase II, New Delhi, Delhi, 110052 |
| Who is the Lead Manager of Medicamen Organics IPO? GYR Capital Advisors Private Limited |
| Who is the Registrar to IPO? Kfin Technologies Limited |
| Medicamen Organics IPO Financial & Analytical Ratios | ||||
| Year | Total Income | Net Profit | EPS | RoNW |
| Rs.in Cr | Rs.in Crore | Rs. | % | |
| 2020-21 | 25.06 | 0.30 | 0.50 | 3.99 |
| 2021-22 | 21.19 | 0.09 | 0.15 | 1.22 |
| 2022-23 | 22.96 | 0.96 | 1.60 | 11.25 |
| Book Value of the Share on | 31.03.2023 | Rs 14.20 | ||
| BV of the Share at cap price | after the IPO | Rs. | ||
| Offer Price/upper band | Rs. 34 | |||
| Medicamen Organics IPO Key Performance indicators |
|
| Price/last EPS of 22-23 | 21.25 |
| Price/BV Ratio | 2.39 |
| Upper price/BV after IPO | – |
How Medicamen Organics IPO compares with the Peers?
| As on date of RHP | FV | Total | PE |
| Rs. | Income | Ratio of | |
| Rs. In Cr | |||
| Medicament Organics | 10 | 22.96 | 21.25 |
| Brooks Laboratories | 10 | 63.41 | 10.60 |
| Cian Healthcare | 10 | 68.10 | 53.84 |
| Zonotech Laboratories | 10 | 43.51 | 38.76 |
# This is only coverage of News related to Grey Market Premium & subject to rates. We do not deal in grey market premium. We do not recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
Medicamen Organics IPO To the point Guidance
Medicamen Organics is engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer. It markets its product to private pharma companies in domestic as well as international markets through third party distributors
or on loan license basis.
Size: The net offer is of Rs. 10.854 Crore/3100000 shares. Retail portion is Rs. 3.48 crore and it can get one time subscribed with 261 applications. The size of the IPO is not very large, looking to the investor frenzy and one time over subscription may not be an issue.
Financial Snapshot: The net profit has increased to Rs. 90 lac during 2022-23 from just Rs. 30 lac in 2020-21. We are not sure whether the company can maintain such high profits in the coming years. The brand is strong. Small application be made.
Quicklinks
Medicamen Organics IPO GMP today details?
Medicamen Organics IPO
Medicamen Organics IPO FAQs
What is Medicamen Organics IPO?
Medicamen Organics is a SME IPO of 2200000 equity shares of the face value of Rs. 5 aggregating up to Rs.11.44 Crores. The issue is priced at Rs.52 per share. The minimum order quantity is 2000 Shares.
When will Medicamen Organics IPO open?
Medicamen Organics IPO opens on June 21, 2024, and closes on June 25, 2024.
What is the lot size of Medicamen Organics IPO?
Medicamen Organics IPO lot size is 4000 Shares, and the minimum amount required is Rs.136000.
How to apply for Medicamen Organics IPO?
You can apply in Medicamen Organics IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
When is Medicamen Organics IPO allotment?
The finalization of Basis of Allotment for Medicamen Organics IPO will be done on 26 June, 2024, and the allotted shares will be credited to your demat account by June 27, 2024.
When is Medicamen Organics IPO listing date?
Medicamen Organics IPO listing date is June 28, 2024.
